Results 21 to 30 of about 12,533 (181)

Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness [PDF]

, 2018
BACKGROUND: There are conflicting data on the effects of antipsychotic medications on delirium in patients in the intensive care unit (ICU). METHODS: In a randomized, double-blind, placebo-controlled trial, we assigned patients with acute ...
Bernard, G.R., Boehm, L.M., Bowton, D.L., Brummel, N.E., Carson, S.S., Chandrasekhar, R., Dittus, R.S., Douglas, I.S., Ely, E.W., Exline, M.C., Feinstein, D.J., Girard, T.D., Gong, M.N., Hite, R.D., Hough, C.L., Hughes, C.G., Hyzy, R.C., Jackson, J.C., Khan, B., Malhotra, A., Masica, A.L., Owens, R.L., Pandharipande, P.P., Patel, M.B., Pisani, M.A., Pun, B.T., Rock, P., Schmidt, G.A., Schweickert, W.D., Stollings, J.L., Strength, C., Thompson, J.L.   +31 more
core   +1 more source

Ziprasidone-induced stuttering： a case report

Sichuan jingshen weisheng, 2022
This paper reported a case of a 25-year-old male schizophrenic patient， who obtained remission from psychotic symptoms during the treatment of olanzapine and trihexylphenidyl， was given ziprasidone treatment additionally due to the occurrence of auditory
Sun Zhenxiao, Liu Huaxue
doaj   +1 more source

Dopamine D2/3 occupancy of ziprasidone across a day : a within-subject PET study [PDF]

, 2013
Rationale Ziprasidone is an atypical antipsychotic recommended to be administered twice daily. Objectives The purpose of this study was to investigate whether occupancy of the dopamine D2/3 receptors by ziprasidone is maintained across a day ...
Borlido, Carol, Caravaggio, Fernando, Deluca, Vincenzo, Graff-Guerrero, Ariel, Ismail, Zahinoor, Mamo, David, Mulsant, Benoit H., Pollock, Bruce G., Remington, Gary, Suzuki, Takefumi, Uchida, Hiroyuki   +10 more
core   +1 more source

Effects of haloperidol and atypical neuroleptics on psychomotor performance and driving ability in schizophrenic patients - Results from an experimental study [PDF]

, 2003
The influence of antipsychotic treatment on the neuropsychological and psychomotor performance of schizophrenic patients is still a subject of investigation.
Kagerer, S., Möller, Hans-Jürgen, Soyka, Michael, Winter, C.   +3 more
core   +1 more source

Modulation of the antipsychotic effect of ziprasidone with nimodipine

Psychiatry and Clinical Psychopharmacology, 2021
Objective: The aim of this study was to examine the effects of chronic administration of ziprasidone, an atypical antipsychotic drug, on experimental models of psychosis and the role of nimodipine, a dihydropyridine calcium channel blocker, on these ...
Bilgin Kaygisiz, Mahmut Ozdemir, Canan Baydemir   +2 more
doaj   +1 more source

Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database [PDF]

, 2013
Background: Drug-induced torsades de pointes (TdP) and related clinical entities represent a current regulatory and clinical burden. Objective: As part of the FP7 ARITMO (Arrhythmogenic Potential of Drugs) project, we explored the publicly available US ...
A Bate, A Clarke, A Pariente, AK Chung, Ariola Koci, B Darpo, BJ Drew, C Meyer-Massetti, DM Roden, DW Hough, E Poluzzi, E Poluzzi, E Poluzzi, E Raschi, E Raschi, Edoardo Spina, Elijah R. Behr, Elisabetta Poluzzi, Emanuel Raschi, EP Puijenbroek van, ER Behr, F Ponti De, F Ponti De, F Rani, Fabrizio De Ponti, GC Alexander, GK Isbister, H Verdoux, J Nielsen, J Papay, K Jolly, K Titier, LC Wittkampf, LS Schneider, Miriam Sturkenboom, NP Tatonetti, P Kannankeril, P Manu, P Vigneault, RC Owens Jr, RR Shah, S Dhillon, S Hennessy, S Kongsamut, S Leucht, SM Straus, Ugo Moretti, W Crumb, W Crumb, WA Ray, WA Ray, WJ Crumb Jr, WP Stephenson, Y Suzuki   +53 more
core   +4 more sources

Continuing lack of evidence for the psychotic subtyping of PTSD [PDF]

, 2011
Universidade Federal de São Paulo, Dept Psychiat, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Psychiat, São Paulo, BrazilWeb of ...
Asevedo, Elson, Brietzke, Elise, Cunham, Graccielle Rodrigues da, Mansur, Rodrigo, Zugman, Andre   +4 more
core   +1 more source

A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson’s Disease

Journal of Parkinson’s Disease, 2019
The atypical antipsychotic ziprasidone has been considered inappropriate for use in patients with Parkinson’s disease (PD), as most atypical antipsychotics worsen parkinsonism.
John R. Younce, Albert A. Davis, Kevin J. Black   +2 more
doaj   +1 more source

Evaluation of intramuscular olanzapine and ziprasidone in the medically ill [PDF]

Mental Health Clinician, 2021
Introduction: Despite the paucity of studies evaluating short-acting parenteral second-generation antipsychotics in the medically ill, their use in this population has increased.
Seema M. Patel, PharmD, BCPP, Ericka L. Crouse, PharmD, BCPP, BCGP, FASHP, FASCP, James L. Levenson, MD   +2 more
doaj   +1 more source

Tardive Dyskinesia in Relation to Estimated Dopamine D2 Receptor Occupancy in Patients with Schizophrenia: Analysis of the CATIE data [PDF]

, 2014
Objective The objective of this study was to evaluate the relationship between antipsychotic-induced tardive dyskinesia (TD) and estimated dopamine D2 receptor occupancy levels in patients with schizophrenia, using the dataset from the Clinical ...
Bies, Robert R., Mimura, Masaru, Mizuno, Yuya, Pollock, Bruce G., Remington, Gary, Suzuki, Takefumi, Uchida, Hiroyuki, Yoshida, Kazunari   +7 more
core   +2 more sources